Integrated Pharma Services — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Integrated Pharma Services is a specialized CRO with a strong focus on antimicrobial and antiviral efficacy testing, serving a diverse clientele from startups to large corporations. Its core competency lies in generating high-quality scientific data for FDA submissions, supported by state-of-the-art BSL-2 labs and a significant biorepository of clinical isolates. The company is ISO 9001:2015 certified, GLP compliant, and DEA registered, positioning it as a trusted partner in the diagnostic and therapeutic product development pipeline. Its business model is entirely service-based, generating revenue through contracted research and consulting.

Infectious DiseaseWound Care

Technology Platform

Integrated CRO service platform featuring specialized microbial expertise, a biorepository of clinical isolates, BSL-2 labs, and regulatory-focused testing/consulting services for antimicrobial and antiviral product development.

Opportunities

The persistent global threat of antimicrobial resistance (AMR) and pandemic preparedness drives sustained demand for specialized antiviral/antimicrobial testing services.

Expansion into government contracting (e.g., BARDA, DoD) and the growing market for regulated psychedelic therapeutics present significant new client avenues.

Risk Factors

Revenue is susceptible to cyclical swings in biotech R&D funding and client concentration.

Intense competition from large, global CROs and other niche players requires continuous demonstration of superior expertise.

Reputational and liability risk is inherent in generating regulatory submission data.

Competitive Landscape

IPS competes in the fragmented CRO market, facing large, full-service players (e.g., Charles River, LabCorp) and smaller niche boutiques. Its differentiation lies in its deep, specific expertise in antimicrobial/antiviral testing, its unique biorepository of clinical isolates, and its integrated regulatory consultation, catering specifically to the infectious disease product development sector.

More companies in Digital Health & Biotech SaaS →More companies in United States →